Sign In
Buy AVEO
$15.00
+0 (+0%)
At Close: Apr 18, 2023
AVEO (AVEO) Stock Jumps 89.1%: Will It Continue to Soar?
05:19am, Thursday, 11'th Mar 2021
AVEO (AVEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AVEO Stock Price Increased 89.11%: Why It Happened
11:01pm, Wednesday, 10'th Mar 2021
The stock price of AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) increased by 89.11%. This is why it happened.
AVEO Announces Appointment of Mike Ferraresso to Chief Commercial Officer
05:52pm, Wednesday, 10'th Mar 2021
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq:AVEO) today announced the appointment of Mike Ferraresso to chief commercial officer. Mr. Ferraresso will be responsible for managing AVEO's commercial s
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved FOTIVDA® (tivozanib) for the treatment of adults with relapsed or r
Earnings Preview: AVEO Pharmaceuticals (AVEO) Q4 Earnings Expected to Decline
01:38pm, Monday, 08'th Mar 2021
AVEO (AVEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVEO Oncology to Present at the H.C. Wainwright Global Life Sciences Conference
07:00am, Tuesday, 02'nd Mar 2021
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will present at the H.C. Wainwright Global Life Sciences Confe
AVEO Oncology Announces Participation at the 2021 SVB Leerink Global Healthcare Conference
07:00am, Thursday, 18'th Feb 2021
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will participate in a fireside chat at the 2021 SVB Leerink Gl
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the presentation of results from the Phase 1b portion of the Phase 1b/2 DEDUCTIVE clinical trial of tivozanib (FOTIVDA®), AVEO's
AVEO Oncology Announces Participation at Two Upcoming Investor Conferences
07:00am, Wednesday, 06'th Jan 2021
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will participate in two upcoming virtual investor conferences:
AVEO Oncology: Managing A Position Ahead Of Tivozanib's PDUFA
06:53am, Sunday, 27'th Dec 2020
AVEO is preparing for the potential U.S. commercial launch for Tivozanib in R/R RCC. The FDA has set the PDUFA Date for March 31st, 2021.
Security Camera Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
12:00am, Thursday, 22'nd Oct 2020
Security Camera market will register an incremental spend of about USD 12 billion, growing at a CAGR of 11.84% during the five-year forecast period.
AVEO (AVEO) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Tuesday, 18'th Aug 2020
AVEO (AVEO) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AVEO Pharmaceuticals' (AVEO) Q2 Earnings Surpass Estimates
12:48pm, Tuesday, 11'th Aug 2020
AVEO (AVEO) reports a narrower-than-expected loss but misses sales estimates in the second quarter of 2020.
AVEO Pharmaceuticals (AVEO) Reports Q2 Loss, Lags Revenue Estimates
11:35pm, Monday, 10'th Aug 2020
AVEO (AVEO) delivered earnings and revenue surprises of 17.65% and -49.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
AVEO Oncology Announces Restructuring of Existing Term Loan with Closing of New Tranched, $35 Million Debt Facility
08:05pm, Monday, 10'th Aug 2020
AVEO Oncology (Nasdaq: AVEO) today announced the closing of a tranched, $35 million debt facility with Hercules Capital, Inc. (NYSE: HTGC) and its affiliates. The new facility has a maturity of 36 mon
